Cardiac protection by long-term treatment with captopril in patients with acute myocardial infarction

Chin Med J (Engl). 1998 Feb;111(2):139-41.

Abstract

Objectives: To assess the effects of long-term angiotensin-converting enzyme (ACE) inhibitor treatment with captopril on cardiac function in acute myocardial infarction (AMI).

Methods: One hundred and one patients with AMI who were admitted to hospital within 72 hours of the onset of symptoms with no cardiogenic shock were randomly allocated to captopril (n = 52; group I) and conventional treatment (n = 49; group II). Left ventricular (LV) systolic performance and diastolic transmitral flow velocity profiles were assessed by Doppler echocardiography at admission (1.2 +/- 1.1 days), before discharge (27 +/- 10 days) and during follow-up (363 +/- 31 days).

Results: At one year follow-up, in group I LV end-diastolic volume decreased, and ejection fraction increased due to a disproportionate decrease in end-systolic volume. The incidence of cardiac dilatation was reduced. LV early diastolic filling velocity (E) increased and late atrial filling velocity (A) decreased, resulting in an elevation of E/A ratio. However, the mean values of LV systolic and diastolic functional parameters were unchanged in group II.

Conclusions: Long-term treatment with captopril exerts a beneficial effect on cardiac protection for patients with AMI.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Captopril / administration & dosage
  • Captopril / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / physiopathology
  • Prospective Studies
  • Ventricular Function, Left / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Captopril